NCT04489927 (T-CORE-PMCF) is a clinical trial of Tcore in Temperature Change, Body, sponsored by Drägerwerk AG & Co. KGaA.

Who is sponsoring NCT04489927?

NCT04489927 is sponsored by Drägerwerk AG & Co. KGaA.

What drugs are being tested in NCT04489927?

Interventions in NCT04489927: Tcore.

What condition does NCT04489927 study?

NCT04489927 studies Temperature Change, Body.

Is NCT04489927 still recruiting?

NCT04489927 is currently terminated. Last updated 22 August 2023.

Last reviewed 2023-08-22 · How we verify

NCT04489927: T-CORE-PMCF

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Validation of the Measurement Accuracy of the Tcore Thermometer

Terminated Last updated 22 August 2023

What this trial tests

trial testing Tcore in Temperature Change, Body in 75 participants. Terminated before completion.

Timeline

1 October 2021

Primary endpoint
11 April 2023

17 April 2023

Quick facts

Lead sponsor	Drägerwerk AG & Co. KGaA
Status	Terminated
Study type	OBSERVATIONAL
Enrollment	75
Start date	1 October 2021
Primary completion	11 April 2023
Estimated completion	17 April 2023
Sites	1 location across Germany

Drugs / interventions tested

Tcore

Conditions studied

Temperature Change, Body — all drugs for Temperature Change, Body →

Sponsor

Drägerwerk AG & Co. KGaA

Who can join

18 and older, any sex, with Temperature Change, Body. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the study conducted at the UKSH is to investigate the measuring accuracy of the body core temperature thermometer Tcore®. Therefore the bias of the measurements to the reference measurements of the bladder catheter thermometer is determined.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Temperature Change, Body

Currently open trials in the same condition.

NCT07032493 — Identifying the Limits of Survivability in Heat-exposed Older Females · NA · recruiting
NCT07174180 — The Impact of Wearing the Hijab on Whole-body Heat Loss During Exercise-heat Stress · NA · recruiting
NCT05765162 — Safe Brain Initiative, Operationalizing Precision Anaesthesia · recruiting
NCT04976712 — Core Temperature in Patients With OHCA · recruiting

Other Drägerwerk AG & Co. KGaA trials

Trials by the same sponsor.

NCT04873999 — Prospective, Open, Non-interventional Study to Assess the Ability of an Electrical Impedance Tomograph (PlumoVista 500) · completed
NCT04698993 — Dräger COVID-19 Antigen Test Clinical Performance Study · NA · terminated
NCT04489914 — Observational Study on the Application of High-Flow Therapy After Percutaneous Transfemoral Aortic Valve Replacement · completed
NCT03076983 — Assessment of the Capability of PulmoVista 500 to Continuously Monitor Changes of Ventilation Over Time · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04489927 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Drägerwerk AG & Co. KGaA
Last refreshed: 22 August 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04489927.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing